Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

iOx Therapeutics

2015 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Developer of therapeutics designed to stimulate the immune system to fight cancer. The company focuses on developing cancer immunotherapy which offers a series of compounds which stimulate an essential component of the immune system, natural killer T cells (NKT) for treatment of cancer.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 5th Floor, Alder Castle
  • 10 Noble Street
  • London EC2V 7QJ
  • England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore iOx Therapeutics’s full profile, request a free trial.

iOx Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 00.000 Completed Startup
2. Early Stage VC 09-Jul-2015 00.000 00.000 00.000 Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

iOx Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view this company’s complete Cap Table, request access »

iOx Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government 000 0000 000000 0
Oxford Sciences Innovation Venture Capital Minority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0

iOx Therapeutics Board Members (4)

Name Representing Role Since Contact
Info
Anna Jenkins iOx Therapeutics Board Member 000 0000
Ian Walters iOx Therapeutics Board Member 000 0000
Jonathan Skipper iOx Therapeutics Board Member 000 0000
Vincenzo Cerundolo Ph.D iOx Therapeutics Founder & Board Member 000 0000